GSTM1 and Miyoshi myopathy: Further analysis detecting the association of miR‐125a with clinical features in MM patients indicated that miR‐125a was negatively associated with ISS stage (P = .001), β2‐MG (P = .002), and LDH (P = .002), while there was no association of miR‐125a with immunoglobulin subtype (P = .445), Durie‐Salmon stage (P = .406), t(4;14) (P = .406) t(14;16) (P = .170), Del (17p) (P = .087), Hb (P = .363), calcium (P = .080), Scr (P = .270), or ALB (P = .197) (Table 3).